, Volume 22, Issue 6, pp 477-484

Adrenocorticosteroid therapy in alcoholic hepatitis

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

In a prospective, randomized, double-blind study of prednisolone therapy of acute alcoholic hepatitis, 39% of the total group of 28 patients died. Mortality and cumulative survival were similar in steroid- and placebo-treated patients. After 14 days of therapy, the serum albumin concentration and white blood count were significantly higher in the steroid group, but all other parameters were similar. An increased risk of fungal infection appeared to be associated with steroid therapy.

Portions of this work were contained in a thesis submitted in partial fulfillment of the requirements for the M.D. degree at Yale University School of Medicine by Dr. Blitzer. Presented in part at the 74th Annual Meeting of the American Gastroenterological Association, May, 1973 (1).